These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2561722)

  • 21. Japanese encephalitis immunization in South Korea: past, present, and future.
    Sohn YM
    Emerg Infect Dis; 2000; 6(1):17-24. PubMed ID: 10653564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Japanese encephalitis vaccine: necessary for the Olympics in Seoul?
    Steffen R
    N Engl J Med; 1988 Jul; 319(4):251. PubMed ID: 2839771
    [No Abstract]   [Full Text] [Related]  

  • 23. National Advisory Committee on Immunization (NACI). Statement on Japanese encephalitis vaccine.
    Can Commun Dis Rep; 1993 Oct; 19(19):160-4. PubMed ID: 8251988
    [No Abstract]   [Full Text] [Related]  

  • 24. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
    Zhou B; Jia L; Xu X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains.
    Kurane I; Takasaki T
    Vaccine; 2000 May; 18 Suppl 2():33-5. PubMed ID: 10821971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fragment of Japanese encephalitis virus envelope protein produced in Escherichia coli protects mice from virus challenge.
    Chia SC; Leung PS; Liao CP; Huang JH; Lee ST
    Microb Pathog; 2001 Jul; 31(1):9-19. PubMed ID: 11427032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Japanese encephalitis vectors in Thailand during 1978-1985.
    Phanthumachinda B
    Southeast Asian J Trop Med Public Health; 1989 Dec; 20(4):635-7. PubMed ID: 2576969
    [No Abstract]   [Full Text] [Related]  

  • 28. Immune status of volunteers one year after administration of Japanese encephalitis vaccine produced in India.
    Saxena SN; Bhau LN; Singh G; Gowal D; Sood YK; Misra CN; Das BK
    Indian J Med Res; 1989 Nov; 89():362-7. PubMed ID: 2559892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Japanese encephalitis vaccines.
    Wkly Epidemiol Rec; 1998 Oct; 73(44):337-44. PubMed ID: 9817024
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunisation against Japanese encephalitis in Nepal: experience of 1152 subjects.
    Henderson A
    J R Army Med Corps; 1984 Oct; 130(3):188-91. PubMed ID: 6098647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis.
    Kumar R; Tripathi P; Rizvi A
    N Engl J Med; 2009 Apr; 360(14):1465-6. PubMed ID: 19339732
    [No Abstract]   [Full Text] [Related]  

  • 32. [Japanese encephalitis: vaccination for some travelers to Asia useful and possible in The Netherlands].
    Kager PA
    Ned Tijdschr Geneeskd; 1993 Aug; 137(35):1755-7. PubMed ID: 8396734
    [No Abstract]   [Full Text] [Related]  

  • 33. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
    Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
    Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological equivalence between mouse brain-derived and Vero cell-derived Japanese encephalitis vaccines.
    Abe M; Shiosaki K; Hammar L; Sonoda K; Xing L; Kuzuhara S; Kino Y; Holland Cheng R
    Virus Res; 2006 Nov; 121(2):152-60. PubMed ID: 16815584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of the outbreak of Japanese encephalitis in Lakhimpur district of Assam in 1989.
    Vajpayee A; Dey PN; Chakraborty AK; Chakraborty MS
    J Indian Med Assoc; 1992 May; 90(5):114-5. PubMed ID: 1325526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Japanese encephalitis vaccination, with reference to travellers to Seoul, Korea.
    Can Dis Wkly Rep; 1988 Sep; 14(36):161-2. PubMed ID: 2852545
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on Japanese B encephalitis virus vaccine from tissue culture. VI. Development of a hamster kidney tissue culture inactivated vaccine for man. 4. Preparation and characterization of vaccine lot for human trial.
    Darwish MA; Hammon WM
    Am J Trop Med Hyg; 1966 Sep; 15(5):765-8. PubMed ID: 4288193
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.
    Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H
    J Gene Med; 2009 Feb; 11(2):150-9. PubMed ID: 19040206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of low dose Japanese encephalitis vaccine (BIKEN) administered by the intradermal route: preliminary data.
    Intralawan P; Paupunwatana S
    Asian Pac J Allergy Immunol; 1993 Jun; 11(1):79-83. PubMed ID: 8216563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.